Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CDRE - US12763L1052 - Common Stock

42.53 USD
+1.71 (+4.19%)
Last: 11/25/2025, 8:04:00 PM
41.68 USD
-0.85 (-2%)
After Hours: 11/25/2025, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, CDRE scores 6 out of 10 in our fundamental rating. CDRE was compared to 71 industry peers in the Aerospace & Defense industry. While CDRE has a great profitability rating, there are some minor concerns on its financial health. CDRE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CDRE had positive earnings in the past year.
In the past year CDRE had a positive cash flow from operations.
Each year in the past 5 years CDRE has been profitable.
Each year in the past 5 years CDRE had a positive operating cash flow.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

CDRE has a Return On Assets of 5.73%. This is in the better half of the industry: CDRE outperforms 70.42% of its industry peers.
With a decent Return On Equity value of 13.33%, CDRE is doing good in the industry, outperforming 78.87% of the companies in the same industry.
CDRE has a better Return On Invested Capital (8.65%) than 74.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CDRE is in line with the industry average of 8.52%.
Industry RankSector Rank
ROA 5.73%
ROE 13.33%
ROIC 8.65%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

Looking at the Profit Margin, with a value of 7.33%, CDRE is in the better half of the industry, outperforming 66.20% of the companies in the same industry.
CDRE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 13.72%, CDRE belongs to the top of the industry, outperforming 80.28% of the companies in the same industry.
CDRE's Operating Margin has improved in the last couple of years.
CDRE has a Gross Margin of 42.68%. This is amongst the best in the industry. CDRE outperforms 83.10% of its industry peers.
In the last couple of years the Gross Margin of CDRE has grown nicely.
Industry RankSector Rank
OM 13.72%
PM (TTM) 7.33%
GM 42.68%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CDRE is destroying value.
Compared to 1 year ago, CDRE has more shares outstanding
CDRE has more shares outstanding than it did 5 years ago.
CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.90 indicates that CDRE is not in any danger for bankruptcy at the moment.
CDRE has a Altman-Z score of 3.90. This is comparable to the rest of the industry: CDRE outperforms 53.52% of its industry peers.
CDRE has a debt to FCF ratio of 5.12. This is a neutral value as CDRE would need 5.12 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.12, CDRE is doing good in the industry, outperforming 70.42% of the companies in the same industry.
CDRE has a Debt/Equity ratio of 0.87. This is a neutral value indicating CDRE is somewhat dependend on debt financing.
CDRE has a Debt to Equity ratio of 0.87. This is in the lower half of the industry: CDRE underperforms 70.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 5.12
Altman-Z 3.9
ROIC/WACC0.85
WACC10.12%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CDRE has a Current Ratio of 3.64. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
CDRE has a Current ratio of 3.64. This is in the better half of the industry: CDRE outperforms 76.06% of its industry peers.
A Quick Ratio of 2.58 indicates that CDRE has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.58, CDRE is doing good in the industry, outperforming 77.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 2.58
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.94% over the past year.
Measured over the past years, CDRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.28% on average per year.
The Revenue has grown by 19.94% in the past year. This is quite good.
The Revenue has been growing slightly by 6.17% on average over the past years.
EPS 1Y (TTM)34.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)19.94%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%42.47%

3.2 Future

CDRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.01% yearly.
CDRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y38.75%
EPS Next 2Y26.41%
EPS Next 3Y20.01%
EPS Next 5YN/A
Revenue Next Year11.34%
Revenue Next 2Y9.51%
Revenue Next 3Y8.99%
Revenue Next 5Y6.3%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 37.97, CDRE can be considered very expensive at the moment.
67.61% of the companies in the same industry are more expensive than CDRE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.98, CDRE is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 29.57, the valuation of CDRE can be described as expensive.
67.61% of the companies in the same industry are more expensive than CDRE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CDRE to the average of the S&P500 Index (35.79), we can say CDRE is valued inline with the index average.
Industry RankSector Rank
PE 37.97
Fwd PE 29.57
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 74.65% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CDRE indicates a rather cheap valuation: CDRE is cheaper than 84.51% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.21
EV/EBITDA 18.38
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDRE has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CDRE's earnings are expected to grow with 20.01% in the coming years.
PEG (NY)0.98
PEG (5Y)N/A
EPS Next 2Y26.41%
EPS Next 3Y20.01%

4

5. Dividend

5.1 Amount

CDRE has a yearly dividend return of 0.96%, which is pretty low.
Compared to an average industry Dividend Yield of 1.15, CDRE pays a better dividend. On top of this CDRE pays more dividend than 84.51% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, CDRE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.96%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

CDRE pays out 33.35% of its income as dividend. This is a sustainable payout ratio.
DP33.35%
EPS Next 2Y26.41%
EPS Next 3Y20.01%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CADRE HOLDINGS INC

NYSE:CDRE (11/25/2025, 8:04:00 PM)

After market: 41.68 -0.85 (-2%)

42.53

+1.71 (+4.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners69.62%
Inst Owner Change4.33%
Ins Owners29.12%
Ins Owner Change-0.34%
Market Cap1.73B
Revenue(TTM)619.07M
Net Income(TTM)45.38M
Analysts78.46
Price Target49.47 (16.32%)
Short Float %9.05%
Short Ratio8.33
Dividend
Industry RankSector Rank
Dividend Yield 0.96%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP33.35%
Div Incr Years1
Div Non Decr Years3
Ex-Date10-31 2025-10-31 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.55%
Min EPS beat(2)1.81%
Max EPS beat(2)11.29%
EPS beat(4)3
Avg EPS beat(4)17.3%
Min EPS beat(4)-31.8%
Max EPS beat(4)87.91%
EPS beat(8)6
Avg EPS beat(8)16.9%
EPS beat(12)9
Avg EPS beat(12)19.2%
EPS beat(16)10
Avg EPS beat(16)13.93%
Revenue beat(2)1
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)0.27%
Revenue beat(4)3
Avg Revenue beat(4)0.61%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)4.48%
Revenue beat(8)5
Avg Revenue beat(8)-0.89%
Revenue beat(12)8
Avg Revenue beat(12)0.27%
Revenue beat(16)11
Avg Revenue beat(16)0.47%
PT rev (1m)25.97%
PT rev (3m)25.97%
EPS NQ rev (1m)-7.8%
EPS NQ rev (3m)-8.29%
EPS NY rev (1m)0%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)1.05%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 37.97
Fwd PE 29.57
P/S 2.79
P/FCF 28.21
P/OCF 26.14
P/B 5.08
P/tB 39.94
EV/EBITDA 18.38
EPS(TTM)1.12
EY2.63%
EPS(NY)1.44
Fwd EY3.38%
FCF(TTM)1.51
FCFY3.54%
OCF(TTM)1.63
OCFY3.83%
SpS15.23
BVpS8.37
TBVpS1.06
PEG (NY)0.98
PEG (5Y)N/A
Graham Number14.52
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 13.33%
ROCE 12.38%
ROIC 8.65%
ROICexc 11.08%
ROICexgc 24.91%
OM 13.72%
PM (TTM) 7.33%
GM 42.68%
FCFM 9.9%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
ROICexc(3y)11.24%
ROICexc(5y)14.1%
ROICexgc(3y)24.24%
ROICexgc(5y)30.41%
ROCE(3y)12.41%
ROCE(5y)17.14%
ROICexgc growth 3Y-11.18%
ROICexgc growth 5Y5.68%
ROICexc growth 3Y-14.82%
ROICexc growth 5Y2.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 5.12
Debt/EBITDA 2.89
Cap/Depr 27.05%
Cap/Sales 0.79%
Interest Coverage 5
Cash Conversion 64.27%
Profit Quality 135.07%
Current Ratio 3.64
Quick Ratio 2.58
Altman-Z 3.9
F-Score6
WACC10.12%
ROIC/WACC0.85
Cap/Depr(3y)35.32%
Cap/Depr(5y)31.71%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.04%
Profit Quality(3y)322.36%
Profit Quality(5y)273.24%
High Growth Momentum
Growth
EPS 1Y (TTM)34.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y38.75%
EPS Next 2Y26.41%
EPS Next 3Y20.01%
EPS Next 5YN/A
Revenue 1Y (TTM)19.94%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%42.47%
Revenue Next Year11.34%
Revenue Next 2Y9.51%
Revenue Next 3Y8.99%
Revenue Next 5Y6.3%
EBIT growth 1Y55.24%
EBIT growth 3Y9.65%
EBIT growth 5Y15.18%
EBIT Next Year72.55%
EBIT Next 3Y29.43%
EBIT Next 5Y20.79%
FCF growth 1Y6.85%
FCF growth 3Y-11.18%
FCF growth 5Y43.24%
OCF growth 1Y4.74%
OCF growth 3Y-7.45%
OCF growth 5Y33.8%

CADRE HOLDINGS INC / CDRE FAQ

Can you provide the ChartMill fundamental rating for CADRE HOLDINGS INC?

ChartMill assigns a fundamental rating of 6 / 10 to CDRE.


Can you provide the valuation status for CADRE HOLDINGS INC?

ChartMill assigns a valuation rating of 6 / 10 to CADRE HOLDINGS INC (CDRE). This can be considered as Fairly Valued.


Can you provide the profitability details for CADRE HOLDINGS INC?

CADRE HOLDINGS INC (CDRE) has a profitability rating of 8 / 10.


What is the valuation of CADRE HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CADRE HOLDINGS INC (CDRE) is 37.97 and the Price/Book (PB) ratio is 5.08.


What is the financial health of CADRE HOLDINGS INC (CDRE) stock?

The financial health rating of CADRE HOLDINGS INC (CDRE) is 5 / 10.